Table 9.
Group* | Estimate | Standard Error | df | T | p-value |
---|---|---|---|---|---|
HIV− GG | 0.2630 | 0.1270 | 4461 | 2.07 | 0.0384 |
HIV+ GG | 0.2640 | 0.1052 | 4661 | 2.51 | 0.0121 |
HIV− AA/AG | 0.3186 | 0.1637 | 4524 | 1.95 | 0.0517 |
HIV+ AA/AG | −0.05818 | 0.1233 | 4546 | −0.47 | 0.6370 |
| |||||
Post Hoc Comparisons** | |||||
| |||||
HIV+ GG vs. HIV+ AA/AG | 0.3222 | 0.1381 | 4452 | 2.33 | 0.0197 |
HIV− AA/AG vs. HIV+ AA/AG | 0.3768 | 0.1630 | 4577 | 2.31 | 0.0208 |
All cases included regardless of stimulant use status
Only significant results are shown